Medicine & Life Sciences
Venous Thromboembolism
100%
Pulmonary Hypertension
97%
Registries
89%
Pulmonary Embolism
84%
Pulmonary Arterial Hypertension
62%
Anticoagulants
42%
3-(2,2,2-trimethylhydrazine)propionate
40%
Mortality
25%
Familial Primary Pulmonary Hypertension
24%
Hemorrhage
23%
Lung
21%
Vitamin K
20%
Dabigatran
20%
Therapeutics
20%
Endarterectomy
19%
Latvia
18%
Energy Metabolism
16%
Monocrotaline
15%
Venous Thrombosis
15%
Atrial Fibrillation
15%
Exercise
14%
Thrombosis
14%
Recurrence
14%
Theoretical Models
14%
Hemodynamics
14%
University Hospitals
12%
Heart Diseases
12%
Upper Extremity Deep Vein Thrombosis
12%
Stroke
11%
Vena Cava Filters
11%
fibrin fragment D
11%
Left Ventricular Dysfunction
11%
Survival
10%
Hereditary Hemorrhagic Telangiectasia
10%
Dasatinib
10%
Balloon Angioplasty
10%
Vascular Resistance
10%
Splenectomy
10%
Neoplasms
10%
Myeloproliferative Disorders
9%
Blood Pressure
9%
Coronavirus
9%
Antiphospholipid Syndrome
9%
Idiopathic Thrombocytopenic Purpura
9%
Natural History
9%
Cardiac Catheterization
8%
Hypothermia
7%
Self Efficacy
7%
Heart Ventricles
7%
Ventricular Pressure
7%